Anzahl der Einträge: 8.
2023
Leich, E.,
Brodtkorb, Marianne,
Schmidt, T.,
Altenbuchinger, Michael,
Lingjærde, Ole Christian,
Lockmer, S.,
Holte, H.,
Nedeva, T.,
Grieb, T.,
Sander, B.,
Sundström, C.,
Spang, Rainer,
Kimby, E. und
Rosenwald, A.
(2023)
Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy.
Leukemia & lymphoma, S. 1-11.
Volltext nicht vorhanden.
2021
Croci, G. A.,
Au-Yeung, R. K. H.,
Reinke, S.,
Staiger, A. M.,
Koch, K.,
Oschlies, I.,
Richter, J.,
Poeschel, V.,
Held, G.,
Loeffler, M.,
Trümper, L.,
Rosenwald, A.,
Ott, G.,
Spang, Rainer,
Altmann, B.,
Ziepert, M. und
Klapper, W.
(2021)
SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status.
Annals of Oncology.
Volltext nicht vorhanden.
2019
Staiger, A. M.,
Altenbuchinger, Michael,
Ziepert, M.,
Kohler, Christian,
Horn, H.,
Huttner, Michael ,
Huttl, K. S.,
Glehr, Gunther ,
Klapper, W.,
Szczepanowski, M.,
Richter, J.,
Stein, H.,
Feller, A. C.,
Moller, P.,
Hansmann, M. L.,
Poeschel, V.,
Held, G.,
Loeffler, M.,
Schmitz, N.,
Trumper, L.,
Pukrop, T.,
Rosenwald, A.,
Ott, G.,
Spang, Rainer ,
Emed Demonstrator Project, und
German High Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL),
(2019)
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL.
Leukemia 34, S. 543-552.
Volltext nicht vorhanden.
2018
Horn, H.,
Kohler, Christian,
Witzig, R.,
Kreuz, M. ,
Leich, E.,
Klapper, W.,
Hummel, M.,
Loeffler, M.,
Trumper, L.,
Spang, Rainer,
Rosenwald, A. und
Ott, G.
(2018)
Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2.
Haematologica.
Volltext nicht vorhanden.
2017
Paul, U.,
Richter, J.,
Stuhlmann-Laiesz, C.,
Kreuz, M. ,
Nagel, I.,
Horn, H.,
Staiger, A. M.,
Aukema, S. M.,
Hummel, M.,
Ott, G.,
Spang, Rainer,
Rosenwald, A.,
Feller, A. C.,
Cogliatti, S.,
Stein, H.,
Hansmann, M. L.,
Moller, P.,
Szczepanowski, M.,
Burkhardt, B.,
Pfreundschuh, M.,
Schmitz, N.,
Loeffler, M.,
Trumper, L.,
Siebert, R. und
Klapper, W.
(2017)
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC.
Leuk. Lymphoma, S. 1-9.
Volltext nicht vorhanden.
2008
Bentink, Stefan,
Wessendorf, S.,
Schwaenen, C.,
Rosolowski, M.,
Klapper, W.,
Rosenwald, A.,
Ott, G.,
Banham, A. H.,
Berger, H.,
Feller, A. C.,
Hansmann, M. L.,
Hasenclever, D.,
Hummel, M.,
Lenze, D.,
Möller, P.,
Stuerzenhofecker, B.,
Loeffler, M.,
Truemper, L.,
Stein, H.,
Siebert, R. und
Spang, Rainer
(2008)
Pathway activation patterns in diffuse large B-cell lymphomas.
Leukemia 22 (9), S. 1746-1754.
Volltext nicht vorhanden.
Dierlamm, J.,
Murga Penas, E. M.,
Bentink, Stefan,
Wessendorf, S.,
Berger, H.,
Hummel, M.,
Klapper, W.,
Lenze, D.,
Rosenwald, A.,
Haralambieva, E.,
Ott, G.,
Cogliatti, S. B.,
Möller, Peter,
Schwaenen, C.,
Stein, H.,
Löffler, M.,
Spang, Rainer,
Trumper, L. und
Siebert, Reiner
(2008)
Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma.
Haematologica 93 (5), S. 688-696.
2007
Blenk, S.,
Engelmann, Julia C.,
Weniger, M.,
Schultz, J.,
Dittrich, M.,
Rosenwald, A.,
Müller-Hermelink, H. K.,
Müller, T. und
Dandekar, T.
(2007)
Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival.
Cancer Informatics 3, S. 399-420.
Diese Liste wurde erzeugt am Thu Nov 21 14:00:11 2024 CET.